Company Diagonal Bio AB

Equities

DIABIO

SE0015961826

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 07:06:18 2024-03-28 am EDT 5-day change 1st Jan Change
0.0882 SEK +4.13% Intraday chart for Diagonal Bio AB +6.65% -75.01%

Business Summary

Diagonal Bio AB is a Sweden-based medical research company. The Company is developing a diagnostic platform (Panviral) for detection of any kind of pathogen. Panviral's technology is based on rapid isothermal amplification of a pathogen's genome. Multiple tests can be run in parallel, thereby increasing the sample throughput.

Number of employees: 4

Sales per Business

SEK in Million2021Weight2022Weight Delta
Diagnostic Platform
100.0 %
0 100.0 % 0 100.0 % -50.12%

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
0 100.0 % 0 100.0 % -50.12%

Managers

Managers TitleAgeSince
Chief Executive Officer - Feb. 27
Founder 48 20-03-18
Director of Finance/CFO 60 20-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 55 20-12-31
Director/Board Member 68 20-12-31
Director/Board Member 39 20-12-31
Founder 33 20-03-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,975,779 28,177,266 ( 70.49 %) 0 70.49 %

Company contact information

Diagonal Bio AB

The Spark Medicon Village

223 81, Lund

+

http://www.diagonalbio.com
address Diagonal Bio AB(DIABIO)